Veterinary Dermatology Drugs Market Set to Exceed USD 5.1 Billion in 2032, says Coherent Market Insights
Burlingame, CA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- The Global Veterinary Dermatology Drugs Market is estimated to be valued at USD 3.04 Bn in 2025 and is expected to reach USD 5.1 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of7.67% from 2025 to 2032. The growth of the veterinary dermatology drugs market is driven by the rising incidence of skin disorders among animals, the increasing rate of pet adoption, and growing awareness regarding animal health and wellness. Additionally, the surge in allergy cases in animals, advancements in veterinary medicine, and the rising demand for innovative drugs to treat animal skin diseases are expected to further propel market growth in the coming years.
Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/5642
Global Veterinary Dermatology Drugs Market Key Takeaways
According to Coherent Market Insights (CMI), the global veterinary dermatology drugs market size is projected to expand from USD 3.04 Bn in 2025 to USD 5.1 Bn by 2032, recording a CAGR of 7.6%.
Demand is expected to remain high for antibiotics, with the target segment accounting for 35% of the global veterinary dermatology drugs market share in 2025.
North America is forecast to account for two-fifths of the global veterinary dermatology drugs industry share by 2025.
Asia Pacific is anticipated to offer lucrative growth opportunities to veterinary dermatology drugs market companies during the forecast period.
Rising Incidence of Skin Diseases in Animals Driving Market Growth
Coherent Market Insights’ latest veterinary dermatology drugs market analysis offers insights into key factors driving industry growth. Increasing prevalence of skin diseases in animals is one such primary growth factor.
The global prevalence of skin diseases like atopic dermatitis, bacterial skin infections, flea/tick allergies, and parasitic infections in animals is increasing significantly. This is likely to increase the demand for veterinary dermatology drugs during the forecast period.
Veterinary dermatology drugs are widely used in animals to treat and prevent various skin conditions. These medications alleviate symptoms such as itching and inflammation. Thus, rising cases of skin diseases in animals are expected to boost growth of veterinary dermatology drugs market.
Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/7163
High Costs and Side Effects Limiting Veterinary Dermatology Drugs Market Growth
The global veterinary dermatology drugs market outlook appears promising due to rising demand for veterinary healthcare products. However, high costs and potential side effects of veterinary dermatology drugs might limit market growth to some extent.
Advanced treatments like immunotherapies and biologics are quite expensive. This makes them less accessible, thereby limiting overall veterinary dermatology drugs market demand.
In addition, continuous use of dermatology drugs, including corticosteroids, antibiotics, and immunosuppressants, can cause adverse side effects. This reduces the uptake, which could slow down growth of the veterinary dermatology drugs market during the forecast period.
Increasing Pet Ownership Unlocking Growth Prospects
Nations like the United States are experiencing high pet adoption rates. For instance, according to the APPA 2025 Industry Report, about 94 million U.S. households own a pet. This is expected to drive demand for veterinary dermatology treatments as more pets develop skin conditions.
Pet owners are increasingly willing to spend more on their veterinary healthcare products like dermatology drugs. As a result, demand for veterinary dermatology drugs is estimated to increase significantly during the forthcoming period.
Emerging Veterinary Dermatology Drugs Market Trends
Rising pet humanization trend is acting as a catalyst for triggering sales of veterinary dermatology drugs. Pet owners in the contemporary world treat their pets as family members, prompting them to invest more in pet healthcare products like dermatology drugs.
Growing interest in preventive healthcare is expected to propel veterinary dermatology drug demand during the assessment period. Pet owners and veterinarians are paying more attention to preventing skin problems, not just treating them. This is encouraging them to invest in veterinary healthcare products like dermatology drugs.
Leading players are developing novel treatments like monoclonal antibodies, JAK inhibitors, immunosuppressants, and improved topical therapies. These innovations in drug development and formulations are expected to boost growth of the veterinary dermatology drugs market in the coming years.
Request For Customization: https://www.coherentmarketinsights.com/insight/request-customization/7163
Analyst’s View
“The global veterinary dermatology drugs industry is expected to grow steadily, owing to rising pet ownership, increasing prevalence of skin diseases in animals, growing pet humanization trend, and innovation in drug development & formulations,” said a lead CMI analyst.
Current Events and Their Impact on the Veterinary Dermatology Drugs Market
| Event | Description and Impact |
| Post-COVID Pet Ownership Surge |
|
| Technological Advancement in Veterinary Diagnostics and Treatment |
|
| Antimicrobial Resistance and One Health Initiative |
|
Competitor Insights
Key companies in veterinary dermatology drugs market report include:
- Zoetis Inc.
- Virbac
- Ceva Sante Animale
- Vetoquinol S.A.
- Elanco Animal Health Incorporated
- Dechra Pharmaceuticals PLC
- Kindred Biosciences, Inc.
- Boehringer Ingelheim International GmbH
- Bayer AG
- IDEXX Laboratories, Inc.
Key Developments
In September 2025, MSD Animal Health launched NUMELVI (atinvicitinib) tablets for dogs. It is a second-generation JAK1-selective inhibitor that provides quick and effective relief from itching. The tablets are approved for treating itching caused by allergic dermatitis, including atopic dermatitis, in dogs.
In September 2024, the U.S. Food and Drug Administration (FDA) approved Zenrelia (ilunocitinib tablets) for allergic skin conditions in dogs. This immunosuppressant is intended to control pruritus (itching) associated with allergic dermatitis.
Market Segmentation
Global Veterinary Dermatology Drugs Market, By Type of Drug
- Antibiotics
- Antifungal drugs
- Anti-inflammatory drugs
- Immunotherapy drugs
- Parasiticides
- Others
Global Veterinary Dermatology Drugs Market, By Animal Type
- Dogs
- Cats
- Horses
- Others
Global Veterinary Dermatology Drugs Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Related Reports:
Veterinary Medicine Market Analysis & Forecast for 2025-2032
Veterinary Antibiotics Market Size, Share, Trends & Opportunities for 2025-2032
Europe Animal Healthcare Market Analysis & Forecast for 2025-2032
Our Trusted Partners:
Worldwide Market Reports, Coherent MI, Stratagem Market Insights
Get Recent News:
https://www.coherentmarketinsights.com/news
About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-8-7924-7805 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com For Latest Update Follow Us: LinkedIn | Facebook | Twitter
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
